-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Exploring Outcomes with Fixed-Duration Treatment in CLL and New Evidence in First-Line AML: Pivotal Clinical Trial Data That Supports Treatment Decisions and Patient Care

Program: Product Theaters
Session: Exploring Outcomes With Fixed-Duration Treatment in CLL and New Evidence in First-Line AML: Pivotal Clinical Trial Data That Supports Treatment Decisions and Patient Care
Monday, December 7, 2020, 10:30 AM-11:30 AM

R. Frank Cornell, MD, MS

AbbVie, Nashville, TN

Disclosures: No relevant conflicts of interest to declare.

See more of: Exploring Outcomes With Fixed-Duration Treatment in CLL and New Evidence in First-Line AML: Pivotal Clinical Trial Data That Supports Treatment Decisions and Patient Care
See more of: Product Theaters